Key facts
- This page summarizes Joel Ackerman's Form 4 filing for CHAMPIONS ONCOLOGY, INC. (CSBR).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 09 Nov 2026, 16:22.
Joel Ackerman - 05 Nov 2026 Form 4 Insider Report for CHAMPIONS ONCOLOGY, INC. (CSBR)
- Reporting relationship
- Director
- Issuer ticker
- CSBR
- Reported as of
- 05 Nov 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 09 Nov 2026, 16:22:06 UTC
- Prior SEC filing
- 16 Oct 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Joel Ackerman
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Joel Ackerman filed Form 4 for CHAMPIONS ONCOLOGY, INC. (CSBR) on 09 Nov 2026.
Change
- Previous filing in this sequence was filed on 16 Oct 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001220630
Primary reporting owner
ACKERMAN JOEL
- Relationship
- Director
- Address
- C/O CHAMPIONS ONCOLOGY, INC., ONE UNIVERSITY PLACE, SUITE 307, HACKENSACK
- Signature
- /s/ Joel Ackerman
- Signature date
- 09 Nov 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CSBR
transaction
Derivative
Option to purchase Common Stock
Award
- Transaction value
- Shares
- +31,216
- Change %
- Price
- $4.76*
- Shares after
- 31,216
- Date
- 05 Nov 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 31,216
- Exercise price
- $4.76
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The options vest and are exercisable over a twelve month period, with vesting to occur on November 5, 2026, February 5, 2027, May 5, 2027 and August 5, 2027, respectively.